E
Evaro
NHS-licensed embeddable prescribing and pharmacy for consumer brands
About Evaro
Evaro is a Norwich NHS-licensed digital healthcare platform founded by emergency doctor Dr Thuria Wenbar (CEO) and pharmacist researcher Dr Oskar Wendowski. It supplies embeddable asynchronous consultations, remote diagnostics, prescribing, dispensing and aftercare so consumer brands can offer regulated online care for common conditions without building their own clinical stack—covering 80+ conditions with CQC registration and an NHS pharmacy licence. Partners have included brands such as Clue and Lovehoney; press cites millions of patients served and integrations that help stream access across large GP networks. In January 2026 Evaro closed a €21 million ($25 million) Series A led by AlbionVC, with Simplyhealth Ventures, Exceptional Ventures, Cornerstone VC and British Business Investments (BBI), to expand its healthcare-as-a-service infrastructure and partner base amid primary-care capacity pressure in the UK. Sources: Tech.eu / EU-Startups 27 Jan 2026; AlbionVC; evaro.com.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- Norwich, United Kingdom
- Employees
- 84
- Open positions
- 5
- Dealroom signal
- 92.3/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Health Care Information Technology, Healthcare IT Management, Health and Wellness, Medical & Healthcare, Medical Data Systems, Core AI, Sustainable Development Goals, Tech for Hospitals and Clinics
- Technology
- Artificial Intelligence, Machine Learning
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES AOther financing | Jan 2026 | $24M | $97M | Cornerstone VC · Exceptional Ventures · Simplyhealth Ventures · AlbionVC | ↗ |
| EARLY VCOther financing | Jul 2025 | $26M | $106M | LifeX Ventures · AlbionVC · Guinness Ventures · British Business Investments | ↗ |
Growth signals
Latest recorded traffic for Evaro is 17K monthly website visits, down 29.2% over the last three months. Evaro's team grew 16.7% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Exceptional Ventures
Cornerstone VC
Syndicate Room
University of East Anglia
Series A6 investors entered at this stage
AlbionVC
LifeX Ventures
Guinness Ventures
British Business Investments
Arve Capital- SVSimplyhealth Ventures
Other known investors1 additional known investor
Google for Startups Accelerator
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Evaro on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Evaro’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.